Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| CardioVascular Research Foundation, Korea | OTHER |
| Boston Scientific Korea Co. Ltd | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate effectiveness and safety of Promus PREMIER in Routine Clinical Practice
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| IRIS PREMIER Cohort | Promus PREMIER |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Promus PREMIER | Device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Composite event rate | Death, non fatal myocardial infarction, Target Vessel Revascularization | 1year |
| Measure | Description | Time Frame |
|---|---|---|
| All death | 5year | |
| Cardiac death | 5year | |
| Myocardial infarction |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
patients with Promus PREMIER stent
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hallym University Sacred Heart Hospital | Anyang | South Korea | ||||
| Soon Chun Hyang University Hospital Cheonan |
This is not a publicly funded trial.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 5year |
| Composite event of death or myocardial infarction | 5year |
| Composite event of cardiac death or myocardial infarction | 5year |
| Target Vessel revascularization | 5year |
| Target lesion revascularization | 5year |
| Stent thrombosis by an Academic Research Consortium (ARC) criteria | 5year |
| Stroke | 5year |
| Procedural success | defined as less than 30% residual stenosis at the completion of procedure without death or Q wave myocardial infarction or urgent revascularization participants will be followed for the duration of hospital stay, an expected average of 3days. | 3day |
| Cheonan |
| South Korea |
| Chungbuk National University Hospital | Cheongju-si | South Korea |
| Gangwon National Univ. Hospital | Chuncheon | South Korea |
| Daegu Catholic University Medical Center | Daegu | South Korea |
| Keimyung University Dongsan Medical Center | Daegu | South Korea |
| Yeungnam University Medical Center | Daegu | South Korea |
| Chungnam National University Hospital | Daejeon | South Korea |
| The Catholic University of Korea, Daejeon ST. Mary's Hospital | Daejeon | South Korea |
| Gangneung Asan Hospital | Gangneung | South Korea |
| Gachon University Gil Hospital | Incheon | South Korea |
| Kwangju Christian Hospital | Kwangju | South Korea |
| Inje University Pusan Paik Hospital | Pusan | South Korea |
| Kosin University Hospital | Pusan | South Korea |
| Pusan National University Hospital | Pusan | South Korea |
| Asan Medical Hospital | Seoul | South Korea |
| Eulji General Hospital | Seoul | South Korea |
| Kangdong Sacred Heart Hospital | Seoul | South Korea |
| Korea University Guro Hospital | Seoul | South Korea |
| Kyunghee University Medical Center | Seoul | South Korea |
| The Catholic University of Korea Seoul St. Mary's Hospital | Seoul | South Korea |
| The Catholic University of Korea St. Paul's Hospital | Seoul | South Korea |
| The Catholic University of Korea Uijeongbu St. Mary's Hospital | Uijeongbu-si | South Korea |
| Ulsan University Hospital | Ulsan | South Korea |
| Pusan National University Yangsan Hospital | Yangsan | South Korea |
| ID | Term |
|---|---|
| D003324 | Coronary Artery Disease |
| D017202 | Myocardial Ischemia |
| D003327 | Coronary Disease |
| D006331 | Heart Diseases |
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided